COVID-19 in immunocompromised hosts: what we know so far

M Fung, JM Babik - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …

[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients

JA Belsky, BP Tullius, MG Lamb, R Sayegh, JR Stanek… - Journal of Infection, 2021 - Elsevier
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …

Coronavirus disease 2019 in solid organ transplant: a multicenter cohort study

OS Kates, BM Haydel, SS Florman… - Clinical Infectious …, 2021 - academic.oup.com
Background The coronavirus disease 2019 (COVID-19) pandemic has led to significant
reductions in transplantation, motivated in part by concerns of disproportionately more …

Interrelations between COVID-19 and other disorders

A Gasmi, M Peana, L Pivina, S Srinath… - Clinical …, 2021 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a respiratory tract
virus that causes Coronavirus disease (COVID-19). The virus originated in Wuhan, China, in …

Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study

JL Pablos, M Galindo, L Carmona, A Lledó… - Annals of the …, 2020 - ard.bmj.com
Objectives The impact of inflammatory rheumatic diseases on COVID-19 severity is poorly
known. Here, we compare the outcomes of a cohort of patients with rheumatic diseases with …

[HTML][HTML] Impact of COVID-19 in solid organ transplant recipients

L Danziger-Isakov, EA Blumberg, O Manuel… - American Journal of …, 2021 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exploded onto the world stage in early …

[HTML][HTML] Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States

MZ Molnar, A Bhalla, A Azhar, M Tsujita… - American Journal of …, 2020 - Elsevier
National data on patient characteristics, treatment, and outcomes of critically ill coronavirus
disease 2019 (COVID-19) solid organ transplant (SOT) patients are limited. We analyzed …

The pediatric solid organ transplant experience with COVID‐19: an initial multi‐center, multi‐organ case series

MB Goss, NTN Galván, W Ruan… - Pediatric …, 2021 - Wiley Online Library
The clinical course of COVID‐19 in pediatric solid organ transplant recipients remains
ambiguous. Though preliminary experiences with adult transplant recipients have been …

Outcomes of COVID‐19 in hospitalized solid organ transplant recipients compared to a matched cohort of non‐transplant patients at a national healthcare system in …

AM Fisher, D Schlauch, M Mulloy, A Dao… - Clinical …, 2021 - Wiley Online Library
Data describing outcomes of solid organ transplant (SOT) recipients with coronavirus
disease 2019 (COVID‐19) are variable, and the association between SOT status and …

[HTML][HTML] Cyclosporine and COVID-19: Risk or favorable?

NN Poulsen, A von Brunn, M Hornum… - American Journal of …, 2020 - Elsevier
The coronavirus disease 2019 (COVID-19) pandemic is declared a global health
emergency. COVID-19 is triggered by a novel coronavirus: severe acute respiratory …